Surfact 108Mg Injection

Surfact 108Mg Injection is generally used to prevent respiratory distress syndrome (RDS) in premature babies. It is a surfactant, and it reduces the incidence of RDS in infants and the probability of infant mortality. It must be administered by physicians or clinicians who are experienced with intubation, ventilator management, and in general, the care of premature babies. It is meant only for intratracheal administration.

The recommended dose of Surfact 108Mg Injection is 5.8 mL per kg of the infant’s birth weight. There must be an interval of at least 6 hours between two consecutive doses. You must not give an infant more than 4 doses of this drug within the first 48 hours of its life. This medicine could cause changes in the lung capacity and oxygenation of the newly born baby, hence, you must ensure that the baby’s lung compliance is repeatedly tested so as to enable the doctors to modify the oxygen and ventilator support in accordance with the change in respiratory status of the infant. There are no contraindications to this medication. While no adverse effects have been reported in cases of overdose, you are advised to aspirate as much of Surfact 108Mg Injection as possible if ventilation, oxygenation or respiration is affected.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Pulmonary Arterial Hypertension (Pah)

• Endotracheal Tube Blockade

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

This medication falls under the category of pulmonary surfactant. It is primarily prescribed to treat respiratory distress syndrome in infants. The exact mechanism of action for the drug is not known, but there are some suspicions as to how the same work.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.